{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:21:04Z","timestamp":1776399664392,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases (NIAID)","doi-asserted-by":"crossref","award":["5UO1-AI078060"],"award-info":[{"award-number":["5UO1-AI078060"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.vaccine.2014.05.053","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T01:17:41Z","timestamp":1401326261000},"page":"4068-4074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model"],"prefix":"10.1016","volume":"32","author":[{"given":"Syed Muaz","family":"Khalil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Tonkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa D.","family":"Mattocks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Snead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7446","key":"10.1016\/j.vaccine.2014.05.053_bib0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.05.053_bib0010","series-title":"Dengue guidelines for diagnosis, treatment, prevention and control","author":"WHO","year":"2009"},{"issue":"12","key":"10.1016\/j.vaccine.2014.05.053_bib0015","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3201\/eid0812.020170","article-title":"Dengue hemorrhagic fever in infants: research opportunities ignored","volume":"8","author":"Halstead","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2014.05.053_bib0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2014.05.053_bib0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2014.05.053_bib0030","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.71.3.1491-1496.2003","article-title":"Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge","volume":"71","author":"Lee","year":"2003","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2014.05.053_bib0035","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1128\/IAI.69.9.5709-5715.2001","article-title":"Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system","volume":"69","author":"Lee","year":"2001","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2014.05.053_bib0040","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1053\/gast.2002.36583","article-title":"Dysregulated peripheral and mucosal Th1\/Th2 response in Whipple's disease","volume":"123","author":"Marth","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.vaccine.2014.05.053_bib0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0264-410X(00)00113-4","article-title":"Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus","volume":"19","author":"Pushko","year":"2000","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2014.05.053_bib0050","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"Pushko","year":"2001","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.05.053_bib0055","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/viro.2001.1012","article-title":"Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins","volume":"286","author":"Wilson","year":"2001","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2014.05.053_bib0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/viro.2000.0635","article-title":"Influenza virus (A\/HK\/156\/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses","volume":"278","author":"Schultz-Cherry","year":"2000","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.vaccine.2014.05.053_bib0065","first-page":"7861","article-title":"Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA","volume":"61","author":"Velders","year":"2001","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.vaccine.2014.05.053_bib0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/viro.1998.9367","article-title":"Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates","volume":"251","author":"Hevey","year":"1998","journal-title":"Virology"},{"issue":"42","key":"10.1016\/j.vaccine.2014.05.053_bib0075","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1016\/j.vaccine.2005.05.034","article-title":"Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660","volume":"23","author":"Johnston","year":"2005","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2014.05.053_bib0080","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1128\/JVI.00512-07","article-title":"An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice","volume":"81","author":"White","year":"2007","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2014.05.053_bib0085","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1128\/JVI.02298-12","article-title":"An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection","volume":"87","author":"White","year":"2013","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2014.05.053_bib0090","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.4049\/jimmunol.169.9.4998","article-title":"Murine neonatal CD4+ lymph node cells are highly deficient in the development of antigen-specific Th1 function in adoptive adult hosts","volume":"169","author":"Adkins","year":"2002","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2014.05.053_bib0095","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri1394","article-title":"Neonatal adaptive immunity comes of age","volume":"4","author":"Adkins","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2014.05.053_bib0100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1074-7613(04)00072-X","article-title":"IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2","volume":"20","author":"Li","year":"2004","journal-title":"Immunity"},{"issue":"25-26","key":"10.1016\/j.vaccine.2014.05.053_bib0105","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/S0264-410X(01)00028-7","article-title":"Neonatal and early life vaccinology","volume":"19","author":"Siegrist","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2014.05.053_bib0110","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0022-3476(98)70395-6","article-title":"Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis","volume":"132","author":"Giuliano","year":"1998","journal-title":"J Pediatr"},{"issue":"21","key":"10.1016\/j.vaccine.2014.05.053_bib0115","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0264-410X(99)00539-3","article-title":"Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster","volume":"18","author":"Tiru","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2014.05.053_bib0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4049\/jimmunol.176.1.165","article-title":"Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival","volume":"176","author":"Pihlgren","year":"2006","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2014.05.053_bib0125","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/1521-4141(200103)31:3<939::AID-IMMU939>3.0.CO;2-I","article-title":"Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life","volume":"31","author":"Pihlgren","year":"2001","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2014.05.053_bib0130","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrmicro1690","article-title":"Prospects for a dengue virus vaccine","volume":"5","author":"Whitehead","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"9853","key":"10.1016\/j.vaccine.2014.05.053_bib0135","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.05.053_bib0140","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","author":"Weiskopf","year":"2013","journal-title":"Proc Nat Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2014.05.053_bib0145","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.4049\/jimmunol.175.5.3431","article-title":"A novel viral system for generating antigen-specific T cells","volume":"175","author":"Moran","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2014.05.053_bib0150","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4269\/ajtmh.2011.10-0592","article-title":"Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques","volume":"84","author":"Osorio","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.05.053_bib0155","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","article-title":"Immune response to dengue virus and prospects for a vaccine","volume":"29","author":"Murphy","year":"2011","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2014.05.053_bib0160","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat Rev Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T23:28:48Z","timestamp":1565479728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14007294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":32,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0264410X14007294"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}